|
|
||||||||
1 Division of Kinesiology and Health, and 2 Department of Animal Science, University of Wyoming, Laramie, Wyoming 82071-3196
| |
ABSTRACT |
|---|
|
|
|---|
Whether or not exercise training of sufficient intensity and duration to produce left ventricle (LV) hypertrophy also regulates deposition of interstitial collagen and cross-linking at the pretranslational level is unknown. Therefore, the effects of exercise training on gene expression for the two principal fibrillar collagens in LV, types I and III, were assessed in young adult (5 mo), middle-aged (15 mo), and old (26 mo) rats. We also evaluated the potential interaction of changes in mRNA for these procollagens with alterations in LV extracellular matrix characteristics by simultaneously measuring collagen concentration (hydroxyproline) and extent of mature collagen cross-linking (hydroxylysylpyridinoline, HP). Ten weeks of treadmill running resulted in LV hypertrophy and an increased maximal oxygen uptake in all three age groups of trained rats compared with sedentary controls. Percent collagen in rat LV almost doubled (P < 0.0001) from 5 to 26 mo of age, an increase unaffected by exercise training. With aging, a significant decline in expression of mRNAs for both collagen type I (P < 0.005) and type III (P < 0.001) was observed in LV free wall (LVF) but not septum (LVS). Training prevented this decline in LVF mRNAs for the two principal fibrillar collagens in middle-aged rats whereas it attenuated the decline in senescent animals. HP concentration increased significantly with aging in both LVF (P < 0.005) and LVS (P < 0.01). Training modulated this effect, but again only in LVF, so that HP was significantly lower (P < 0.05) in this region of the LV in old trained rats compared with sedentary counterparts. We conclude that exercise training modulates the effects of aging on collagen gene mRNAs and HP cross-linking regionally within the LV.
hydroxylysylpyridinoline; myocardial interstitium
| |
INTRODUCTION |
|---|
|
|
|---|
IT IS RECOGNIZED THAT AN INCREASE in collagen concentration is observed as an integral part of extracellular matrix (ECM) remodeling that takes place in left ventricle (LV) consequent to the natural aging process (12, 15, 33) as well as in response to a variety of pathologies resulting in hypertrophy of this chamber (4, 8, 10, 17, 20, 21, 28). However, as first pointed out by Bartosova et al. (1), disproportionate collagen accumulation and/or interstitial fibrosis are not obligatory responses of the ECM to left ventricular hypertrophy (LVH), as normal collagen concentrations are seen in several other LVH models including anemia, arteriovenous fistula, and exercise training. The functional significance of myocardial fibrosis was elucidated by Boluyt et al. (5) in a pressure-overload LVH model using the spontaneously hypertensive rat. In this study, transition from stable hypertrophy to failure was associated with a four- to fivefold increase in expression of procollagen type I and III mRNAs. Although Boluyt et al. (5) did not evaluate the quality (degree of cross-linking) of the hypertrophied myocardial ECM, Norton et al. (32) attributed the observed increase in myocardial stiffness in this same model to alterations in collagen cross-linking profile as opposed to changes in total collagen or phenotype ratios.
In the present study, we evaluated the single and interactive effects of aging and exercise training on gene expression for procollagen types I and III in rat LV. Exercise training has previously been shown to increase myocardial prolyl 4-hydroxylase, an enzyme with an activity level that correlates positively with collagen biosynthesis (37). Because training failed to alter amount of LV collagen (hydroxyproline) in this same study, the findings were interpreted as being indicative of an increase in collagen turnover rate that could potentially alter collagen characteristics even if concentration remains unchanged. This hypothesis was confirmed by the finding that the principal nonreducible collagen cross-link in LV, hydroxylysylpyridinoline (HP), was significantly reduced as a result of exercise training in old rats (38). This result indicated that exercise training affects LV collagen metabolism posttranslationally in the myocardial ECM. Determining whether or not this same intervention impacts any age-associated changes in gene expression of the two principal fibrillar collagens found in the heart was the primary purpose of the present investigation. In this manner, we sought to determine whether a point of regulation of interstitial collagen deposition and cross-linking, and by implication its maturation and stiffness characteristics, occurs at the pretranslational level.
| |
METHODS |
|---|
|
|
|---|
Animals. Young (10-wk-old), middle-aged (12-mo-old), and old (24 mo old) female Fischer 344 pathogen-free rats were obtained from the National Institute on Aging colony. Animals were housed in a climate-controlled room (25°C, 12-h light-dark cycle) and allowed food and water ad libitum.
Training.
Rats within a given age group were weight-matched and randomly assigned
into exercise training and sedentary control groups. This resulted in
the following groups: young control, young trained, middle-aged
control, middle-aged trained, old control, and old trained. Before
training, all rats were familiarized with a Stanhope small animal
treadmill by walking/running for 10 min/day for 5 days. Training was
carried out in a manner similar to that previously performed in our
laboratory (45). In brief, young, middle-aged, and old
rats assigned to the training groups commenced training at 15, 13, and
10 m/min, respectively, for 50 min/day. This was progressively
increased throughout the 10-wk training program, so that at its
termination rats in the three age groups were running continuously at
30, 24, and 15 m/min for 60 min/day, 5 days/wk. This training program
has previously been shown to produce LVH as well as to increase aerobic
enzyme activity in locomotor muscle of the rat (38).
Sedentary groups walked/ran on the treadmill 10 min daily to ensure
similar handling and to maintain familiarity with the treadmill for
subsequent testing of maximal oxygen uptake (
O2 max) (see below).
O2 max.
To assess the efficacy of the training program,
O2 max was determined via flow-through
spirometry techniques employing a small-animal metabolic chamber, as
described previously (45).
Tissue removal. Forty-eight hours after the conclusion of the 10-wk training program, rats were deeply anesthetized with pentobarbital sodium (50 mg/kg ip). With the use of sterile techniques, a pneumothorax was performed, and the animals were killed by removal of the heart. Both atria and right ventricle were immediately trimmed off, and the LV was divided into free wall (LVF) and septum (LVS) (28) and weighed before being flash-frozen and maintained in liquid nitrogen.
Total RNA isolation.
Total RNA was extracted using the methods described by Strohman et al.
(36) and MacDonald et al. (25). Frozen tissue
was homogenized, on ice, in 4 M guanidine thiocyanate. For every 750 µl of homogenate, the following substances were added, followed by
vortexing, in order: 50 µl of 2 M sodium acetate, 500 µl phenol, and 100 µl of a 49:1 chloroform-isoamyl alcohol mixture. After centrifugation (10,000 g for 20 min at 4°C), the
supernatant was transferred to a fresh tube and 500 µl of isopropanol
were added. The mixture was frozen (
20°C) for at least 1 h and
then recentrifuged. The pellet was collected and dissolved in 150 µl
of 4 M guanidine thiocyanate; 500 µl of isopropanol were then added,
and the solution was again frozen (
20°C) for at least 1 h.
Total RNA was pelleted by centrifugation, purified by ethanol
precipitation, and quantified by absorbance at 260 nm, assuming 40 mg/ml for each unit of absorbance.
Northern hybridization.
Messenger RNA levels were determined by Northern and dot-blot
hybridization analyses by the use of methods adapted from those of
Lehrach et al. (24) and Goldberg (16). Total
mRNA (10 µg) was denatured in 50% formamide, 17.5% formaldehyde,
and 1× MOPS buffer (20 mM MOPS; 5 mM sodium acetate, pH 6.5; 1 mM
EDTA, pH 8.0; pH total solution to 7.0), electrophoresed through a
1.2% agarose gel, and transferred to a nylon membrane (Biotrans, Pall BioSupport, East Hills, NY). The membrane was baked (2 h at 80°C) in
a vacuum oven. Prehybridization of blots took place for 8 h at
42°C in prehybridizing buffer (5× standard saline citrate; 0.1%
sodium dodecyl sulfate; 5× Denhardt's solution; 50% deionized formamide; 0.1 M phosphate buffer, pH 7.0; and 100 mg/ml salmon sperm DNA). Hybridization was performed at 42°C using the same buffer, without salmon sperm DNA, containing the appropriate
radioactive probes to obtain 3 × 106
counts · min
1 · ml hybridization
medium
1.
-32P]dCTP (specific
activity 3,000 Ci/mM, New England Nuclear, Wilmington, DE) was included
in the reaction mixture to obtain a specific activity between 2 and
6 × 108
counts · min
1 · mg
DNA
1. DNA fragments were radiolabeled by Klenow
DNA polymerase-catalyzed extension of random primers. Rat
1(I) procollagen (1,074 bp) and
1(III)
procollagen (449 bp) inserts, isolated from recombinant plasmid
PGEM7Zf(
), were used as probes. A full-length cDNA for human g-actin
was used as a control. Hybridized membranes were washed and exposed to
film at
70°C.
Dot blot hybridization. For dot blot hybridization, 5 µl of total RNA were incubated (15 min at 65°C) in 50% formamide, 7% formaldehyde, and 1× standard saline citrate. The mixture was spotted onto the nylon membrane using a Minifold I following the procedure described by Sambrook et al. (35). Membranes were baked before prehybridization as described above. Dots were quantified for relative amounts of mRNA by densitometry.
Hydroxylysylpyridinoline.
Tissue samples homogenized in 4 M guanidine thiocyanate to isolate RNA
were centrifuged, and the supernatant was removed. The remaining solid
was lyophilized and stored at
70°C for subsequent analysis. The
degree of collagen cross-linking was assessed by using the
reverse-phase high-performance liquid chromatography methods of Eyre et
al. (13) with modifications described previously by us
(28).
Hydroxyproline. Collagen concentration was calculated from colorimetric determination of hydroxyproline concentration by the method of Woessner (42). Collagen concentration was calculated assuming that collagen weighs 7.25 times hydroxyproline and has a molecular weight of 300,000.
Statistical analysis.
Data were analyzed by two-way ANOVA for aging and training main effects
as well as for aging-training interactions. Post hoc contrasts to
determine differences between means were also carried out when
appropriate with
set at 0.05. The statistical program SuperANOVA
(Abacus Concepts, Berkeley, CA) was used for all analyses.
| |
RESULTS |
|---|
|
|
|---|
Body and heart weights.
Whole body weight (BW), LV weight, and LV-to-BW ratio for the six
groups are shown in Table 1. Although
exercise had no effect on BW, an overall increase with aging was
observed. Although there were significant aging and training main
effects for both LV weight and LV-to-BW ratios, significant
age-by-training interactions for these parameters (both
P < 0.05) also occurred. Post hoc analysis indicated that the effects of training on the heart were more pronounced in younger and middle-aged animals, compared with older animals (Table 1).
|
O2 max.
Treadmill running at age-adjusted speeds for a period of 10 wk
significantly increased whole body
O2 max in all three trained groups
compared with age-matched sedentary counterparts (Fig.
1).
|
LV collagen characteristics.
Percent collagen in LVF and LVS from young, middle-aged, and old
sedentary and trained rats is shown in Fig.
2. Percent collagen in LV ECM increased
progressively from young adulthood to senescence so that values at 26 mo were higher than those at both 5 and 15 mo, which in turn were also
significantly different from each other. Training had no effect on LV
collagen concentration at any age level. As shown in Fig.
3, there were significant overall aging-related increases in HP cross-linking for both LVF
(P < 0.005) and LVS (P < 0.01).
Exercise modulated this effect, but only in LVF, in which the
training-induced attenuations were significant for the old trained vs.
sedentary comparison (P < 0.05, Fig. 3).
|
|
LV collagen mRNA expression.
A significant overall decline in expression of mRNAs for both
procollagen type I (P < 0.005) and type III
(P < 0.001) was seen with aging in LVF but not in LVS.
Although exercise training did not prevent the overall decline seen in
both procollagen types I and III in LVF, it had the effect of
attenuating this decline. Thus LVF procollagen types I and III levels
in middle-aged trained rats were significantly elevated over
age-matched sedentary peers and no different from levels seen in young
sedentary controls. Likewise, mRNA levels for the two principal
fibrillar collagen phenotypes were significantly elevated in LVF from
old trained rats compared with old sedentary animals and no different
from those seen in middle-aged sedentary rats (Figs.
4 and 5).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
We were interested in elucidating the relationship between alterations in pretranslational levels of expression for the principal fibrillar collagens in LV and changes in ECM characteristics of this same chamber. The principal findings from the study were that a relatively short period of exercise training (10 wk), but one of sufficient intensity and duration to produce a mild LVH, reverses aging-associated declines in myocardial fibroblast expression for procollagen types I and III in LVF of middle-aged and old rats. Additionally, it attenuates the increases in ECM collagen cross-linking seen in the same region of the LV in old sedentary rats. These changes occur without affecting the overall increase in collagen concentration seen in this chamber with aging.
Relationship between collagen gene expression and collagen cross-linking. The deposition of collagen in the ECM depends on the production and secretion of properly transcribed, translated, and processed protein molecules and on cellular, gene-, and enzyme-mediated processes. Collagen cross-linking is obligatorily an ECM event, not directly under gene control. Enzyme-derived cross-links occur between collagen molecules and fibrils, and their formation is dependent on relationships among and between fibrillar collagen molecules. Cross-linking residues on adjacent collagen molecules or fibrils must be precisely aligned for cross-linking to proceed (13). Such a requirement indicates that spatial relationships between type I and III collagens are likely a controlling factor in cross-linking formation (34, 40). Populations of collagen molecules and fibrils may exist in different arrays and varying frequencies. All known lysine-derived cross-links are restricted to four sites per collagen molecule, and fibril orientation could affect both divalent and trivalent cross-link formation (13, 18). Thus perturbations in mRNA levels for the fibrillar collagens I and III suggest ongoing anabolic activity that would be reflected in protein deposition in the ECM, and such activity would be expected to affect cross-linking. However, there may be positive or negative relationships between variations in gene expression and cross-linking. For example, in pathological models of LVH, e.g., myocardial infarction, there are significant increases in collagen gene expression concomitant with increased collagen deposition and increased cross-linking (unpublished findings). The significance of increased protein synthesis and ECM deposition is the potential to also alter cross-linking profiles. We have discussed nonreducible collagen cross-linking and its potential regulation in several recent reviews (29, 30, 34).
LV collagen metabolism and aging. The present findings extend our understanding of aging and its effects on collagen metabolism in the normal healthy heart (2, 26, 27, 29, 38). Our results with respect to mRNAs for type I and III collagen in LVF, which makes up ~70% of the mass of the entire LV in the Fischer 344 strain of rat employed (28), are in general agreement with those of Besse et al. (2). These investigators reported significant declines in both type I and type III procollagen mRNA levels in rat LV from 3 to 24 mo of age. In the present study, although reductions in procollagen types I and III levels were seen in LVF with aging, they were maintained in LVS, again pointing out regional differences in collagen metabolism within the normal left ventricle (28) and in response to myocardial infarction (6). Simultaneously, percent LV collagen increased with age, as did HP cross-linking for both free-wall and septal regions of this chamber. These results imply reduced collagen turnover with aging, with degradation rates falling faster than simultaneously declining synthesis rates (4, 23), a process that allows for greater maturity of collagen as indicated by higher concentrations of the HP cross-link (34). The ECM remodeling associated with both aging and training in the present study thus differs from that seen in a variety of pathological cardiac hypertrophy models.
Collagen metabolism in other LVH models.
Alterations in collagen metabolism and associated fibrosis are seen in
a variety of heart pathologies. These include both pressure- (8,
10, 17, 20, 21) and volume-overload (17, 19) models
of LVH. Alterations in wall stress resulting from myocardial infarction
(33) are also thought to provide a potent stimulus to the
ECM, resulting in a reactive fibrosis of viable myocardium quite
separate from the reparative fibrosis associated with tissue necrosis
and infarct formation (28, 39, 41). In the same model, 5- to 15-fold increases in type I and III procollagen mRNAs have been
observed in both infarcted and noninfarcted (septal) areas of LV with
the specifics and time course of the response differing somewhat
between regions (9). The increase in collagen concentration and altered stiffness characteristics of the left ventricle in these and other experimental models (7) are
thought to play a role in the simultaneously observed depression of
selected contractility indexes, which may ultimately result in heart
failure (5, 6, 10). In the pressure-overload model of LVH,
as well as that produced by norepinephrine (3, 8, 11), the observed fibrosis is accompanied by an increase in mRNA for
pro-
2 (I) collagen and transforming growth
factor-
1, implying that collagen biosynthesis is being
regulated, at least in part, at the level of the gene by cardiac
fibroblasts (11).
Exercise training and collagen metabolism. The effects of exercise training on expression of message for the two principal collagens differ from those seen in the aforementioned pathological hypertrophy models in terms of both extent and duration of response. The principal effect of training seems to be one of preserving the decline in expression of mRNAs for type I and III collagen seen with aging, in contrast to the 5- to 15-fold increase in these same mRNAs associated with myocardial infarction, for example (9). Likewise, dramatic increases in these mRNAs have largely returned to control levels in functioning myocardium by 13 wk postinfarction, whereas in the abdominal aortic constriction model (8), transient sixfold increases in levels of mRNAs for both collagen type I and III had declined to control levels 7 days postbanding. In the present study, the stimulus for increased expression of the mRNAs is apparently maintained even 10 wk after inception of the training program, perhaps because of the progressively increasing intensity of exercise employed throughout the duration of the program. Whether it is alterations in hemodynamic load on the heart that is providing the stimulus for the observed elevation in LVF collagen mRNAs in trained compared with sedentary rats in the older age group, or some other exercise-related alteration in hormonal milieu that is affecting rates of myocardial collagen synthesis and degradation, is an interesting question posed by the findings of the present study.
Whatever the stimulus, the increased expression for type I and III collagens in LV of trained middle-aged and senescent rats compared with age-matched sedentary controls does not affect percentage of collagen measured in this chamber. This finding in turn implies that whatever increase in collagen synthesis occurs is matched by increased degradation rates, providing an explanation for the simultaneous observation of a training-induced reduction in HP cross-linking. The ANOVA statistical design employed in the present study indicated an overall training effect for HP in LVF, although reductions in cross-linking were only significant in the oldest group of animals, thus confirming our previous finding in this regard (38). Using a more recently developed technique (28) for measuring these cross-links did, however, indicate that cross-linking in rat LV is significantly higher than previously reported (38). The conclusion of Woodiwiss et al. (43) that alterations in cross-linking characteristics play no role in the reduced cardiac stiffness they observed in young trained animals may be incorrect. In their study, the lysine-derived cross-links were not measured directly but rather were estimated by amount of extracted collagen after cyanogen bromide digestion. Use of collagen solubility as a measurement of collagen cross-linking is less than robust. They reported a trend toward increased type III but not type I solubility. Because nonreducible cross-linking in mixtures of type I and type III collagen phenotypes does not occur between type I molecules, no change in type I collagen solubility would be expected. In the present study, we report only subtle training-induced changes in nonreducible cross-linking in young and middle-aged rats. A nonspecific measure of collagen cross-linking such as reduced solubility may be insufficiently precise to detect small differences in specific cross-links. Whether the findings with respect to HP cross-linking of the present study also imply a more economical cost of cardiac contraction and/or improved diastolic function in the aged trained heart is a hypothesis requiring further investigation.| |
ACKNOWLEDGEMENTS |
|---|
We gratefully acknowledge the excellent technical assistance of Liqiang Huang.
| |
FOOTNOTES |
|---|
This research was supported in part by grants from the American Heart Association, Wyoming affiliate (9206228S and 9306266S) awarded to D. P. Thomas and R. J. McCormick, respectively.
Address for reprint requests and other correspondence: D. P. Thomas, Div. of Kinesiology and Health, P. O. Box 3196, Univ. of Wyoming, Laramie, WY 82071 (E-mail: cymru{at}uwyo.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 29 December 1999; accepted in final form 2 May 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bartosova, D,
Chvapil M,
Korecky B,
Poupa O,
Rakusan K,
Turek Z,
and
Vizek M.
The growth of the number of collagenous parts of the heart in various forms of cardiomegaly.
J Physiol (Lond)
200:
285-295,
1969
2.
Besse, S,
Robert V,
Assayag P,
Delcayre C,
and
Swynghedauw B.
Nonsynchronous changes in myocardial collagen mRNA and protein during aging: effect of DOCA-salt hypertension.
Am J Physiol Heart Circ Physiol
267:
H2237-H2244,
1994
3.
Bhambi, B,
and
Eghbali M.
Effects of norepinephrine on myocardial gene expression and response of cardiac fibroblasts after norepinephrine treatment.
Am J Pathol
139:
1131-1143,
1991[Abstract].
4.
Bishop, JE,
and
Laurent GJ.
Collagen turnover and its regulation in the normal and hypertrophying heart.
Eur Heart J
16:
38-44,
1995.
5.
Boluyt, MO,
O'Neill L,
Meredith AL,
Bing OHL,
Brooks WW,
Conrad CH,
Crow MT,
and
Lakatta EG.
Alterations in cardiac gene expression during transition from stable hypertrophy to heart failure.
Circ Res
75:
23-32,
1994
6.
Capasso, JM,
Li P,
Zhung X,
and
Anversa P.
Heterogeneity of ventricular modeling after acute myocardial infarction.
Am J Physiol Heart Circ Physiol
262:
H486-H495,
1992
7.
Capasso, JM,
Robinson TF,
and
Anversa P.
Alterations in collagen cross-linking impair myocardial contractility in the mouse heart.
Circ Res
65:
1657-1664,
1989
8.
Chapman, D,
Weber KT,
and
Eghbali M.
Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium.
Circ Res
67:
787-794,
1990
9.
Cleutjens, JPM,
Verluyten MJA,
Smits JFM,
and
Daemen MJAP
Collagen remodeling after myocardial infarction in the rat heart.
Am J Pathol
147:
325-338,
1995[Abstract].
10.
Conrad, CH,
Brooks WW,
Hayes JA,
Sen S,
Robinson KG,
and
Bing OHL
Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat.
Circulation
91:
161-170,
1995
11.
Eghbali, M.
Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation.
In: Cardiac Adaptation in Heart Failure, edited by Holtz J,
Drexler H,
and Just H.. Darmstadt, Germany: Steinkopff, 1992, p. 183-189.
12.
Eghbali, M,
Eghbali M,
Robinson TF,
Seiter S,
and
Blumenfeld OO.
Collagen accumulation in heart ventricles as a function of growth and aging.
Cardiovasc Res
23:
723-729,
1989[ISI][Medline].
13.
Eyre, DR,
Paz MA,
and
Gallop PM.
Cross-linking in collagen and elastin.
Annu Rev Biochem
53:
717-748,
1984[ISI][Medline].
14.
Feinberg, AP,
and
Vogelstein B.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
Anal Biochem
132:
6-13,
1983[ISI][Medline].
15.
Feinberg, AP,
and
Vogelstein B.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity: addendum.
Anal Biochem
137:
266-267,
1984[ISI][Medline].
16.
Goldberg, DA.
Isolation and partial characterization of the Drosophila alcohol dehydrogenase gene.
Proc Natl Acad Sci USA
77:
5794-5798,
1980
17.
Harper, J,
Harper E,
and
Covell JW.
Collagen characterization in volume-overload- and pressure-overload-induced cardiac hypertrophy in minipigs.
Am J Physiol Heart Circ Physiol
265:
H434-H438,
1993
18.
Henkel, W,
and
Glanville RW.
Covalent crosslinking between molecules of type I and type III collagen. The involvement of N-terminal, nonhelical regions of the
1 (I) and
2 (III) chains in the formation of intermolecular crosslinks.
Eur J Biochem
122:
205-213,
1982[ISI][Medline].
19.
Iimoto, DS,
Covell JW,
and
Harper E.
Increase in cross-linking of type I and III collagens associated with volume-overload hypertrophy.
Circ Res
63:
399-408,
1988
20.
Jalil, JE,
Doering CW,
Janicki JS,
Pick R,
Shroff SG,
and
Weber KT.
Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle.
Circ Res
64:
1041-1050,
1989
21.
Jalil, JE,
Doering CW,
Janicki JS,
Pick R,
Clark WA,
and
Weber KT.
Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle.
J Mol Cell Cardiol
20:
1179-1187,
1988[ISI][Medline].
22.
Karim, MA,
Ferguson AG,
Wakim BT,
and
Samarel AM.
In vivo collagen turnover during development of thyroxin-induced left ventricular hypertrophy.
Am J Physiol Cell Physiol
260:
C316-C326,
1991
23.
Laurent, GJ.
Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass.
Am J Physiol Cell Physiol
252:
C1-C9,
1987
24.
Lehrach, H,
Diamond C,
Wozney JM,
and
Boedtker H.
RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.
Biochemistry
16:
4743-4751,
1977[Medline].
25.
MacDonald, RJ,
Swift GH,
Przybyla AE,
and
Chirgwin JM.
Isolation of RNA using guanidinium salts.
Methods Enzymol
152:
219-227,
1987[ISI][Medline].
26.
Mays, PK,
Bishop JE,
and
Laurent GJ.
Age-dependent changes in the proportion of types I and III collagen.
Mech Ageing Dev
45:
203-212,
1988[ISI][Medline].
27.
McAnulty, RJ,
and
Laurent GJ.
Collagen synthesis and degradation in vivo: evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat.
Coll Relat Res
7:
93-104,
1987[ISI][Medline].
28.
McCormick, RJ,
Musch TI,
Bergman BC,
and
Thomas DP.
Regional differences in LV collagen accumulation and mature collagen cross-linking after myocardial infarction in rats.
Am J Physiol Heart Circ Physiol
266:
H354-H359,
1994
29.
McCormick, RJ,
and
Thomas DP.
Collagen crosslinking in the heart: relationship to development and function.
Basic Appl Myol
8:
143-150,
1998.
30.
McCormick, RJ,
and
Phillips AL.
Muscle extracellular matrix: role in growth, development and meat tenderness.
In: Quality Attributes in Muscle Foods, edited by Xiong YL,
Ho C-T,
and Shakida F.. New York: Kluwer Academic, 1999, p. 219-228.
31.
Medugorac, I,
and
Jacob R.
Characterization of left ventricular collagen in the rat.
Cardiovasc Res
68:
856-869,
1983.
32.
Norton, GR,
Tsotetsi J,
Trifunovic B,
Hartford C,
Candy GP,
and
Woodiwiss AJ.
Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotype in spontaneously hypertensive rats.
Circulation
96:
1991-1998,
1997
33.
Olivetti, G,
Capasso JM,
Meggs LG,
Sonnenblick EH,
and
Anversa P.
Cellular basis of chronic ventricular remodeling after myocardial infarction in rats.
Circ Res
68:
856-869,
1991
34.
Reiser, K,
McCormick RJ,
and
Rucker RB.
Enzymatic and nonenzymatic cross-linking of collagen and elastin.
FASEB J
6:
2439-2449,
1992[Abstract].
35.
Sambrook, J,
Fritsch EF,
and
Maniatis T.
Molecular Cloning: A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
36.
Strohman, RC,
Moss PS,
Micou-Eastwood J,
Spector D,
Rozybyla A,
and
Paterson B.
Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures.
Cell
10:
265-273,
1977[ISI][Medline].
37.
Takala, TES,
Ramo P,
Kiviluoma K,
Vikho V,
Kainulainen H,
and
Kettunen R.
Effects of training and anabolic steroids on collagen synthesis in dog heart.
Eur J Appl Physiol
62:
1-6,
1991.
38.
Thomas, DP,
McCormick RJ,
Zimmerman SD,
Vadlamudi RK,
and
Gosselin LE.
Age- and training-induced alterations in collagen characteristics of rat left ventricle and papillary muscle.
Am J Physiol Heart Circ Physiol
263:
H778-H783,
1992
39.
Van Krimpen, C,
Smits JFM,
Cleutjens JPM,
Debets JJM,
Schoemaker RG,
Struyker Boudier HAJ,
Bosman FT,
and
Daemen MJAP
DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril.
J Mol Cell Cardiol
23:
1245-1253,
1991[ISI][Medline].
40.
Velleman, SG,
Yeager JD,
Krider H,
Carrino DA,
Zimmerman SD,
and
McCormick RJ.
The avian low score normal weakness alters decorin expression and collagen crosslinking.
Connect Tissue Res
34:
33-39,
1996[ISI][Medline].
41.
Volders, PGA,
Willems IEMG,
Cleutjens JPM,
Arends JW,
Havenit MG,
and
Daemen MJAP
Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction.
J Mol Cell Cardiol
25:
1317-1323,
1993[ISI][Medline].
42.
Woessner, JF.
The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.
Arch Biochem Biophys
93:
440-447,
1961[ISI][Medline].
43.
Woodiwiss, AJ,
Oosthuyse T,
and
Norton GR.
Reduced cardiac stiffness following exercise is associated with preserved myocardial collagen characteristics in the rat.
Eur J Appl Physiol
78:
148-154,
1998.
44.
Yao, J,
and
Eghbali M.
Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy.
Circ Res
71:
831-839,
1992
45.
Zimmerman, SD,
McCormick RJ,
Vadlamudi RK,
and
Thomas DP.
Age and training alter collagen characteristics in fast- and slow-twitch rat limb muscle.
J Appl Physiol
75:
1670-1674,
1993
This article has been cited by other articles:
![]() |
L. Groban, H. Jobe, M. Lin, T. Houle, D. A. Kitzman, and W. Sonntag Effects of Short-Term Treadmill Exercise Training or Growth Hormone Supplementation on Diastolic Function and Exercise Tolerance in Old Rats J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2008; 63(9): 911 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Hwang, G. Cirrincione, D. P. Thomas, R. J. McCormick, and M. O. Boluyt Aldosterone Antagonism Fails to Attenuate Age-Associated Left Ventricular Fibrosis J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
P E Gates and D R Seals Decline in large elastic artery compliance with age: a therapeutic target for habitual exercise Br. J. Sports Med., November 1, 2006; 40(11): 897 - 899. [Full Text] [PDF] |
||||
![]() |
J. P. Konhilas, P. A. Watson, A. Maass, D. M. Boucek, T. Horn, B. L. Stauffer, S. W. Luckey, P. Rosenberg, and L. A. Leinwand Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy Circ. Res., March 3, 2006; 98(4): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Walker Jr., M. S. Nillas, E. I. Mangiarua, S. Cansino, R. G. Morrison, R. R. Perdue, W. E Triest, G. L. Wright, M. Studeny, P. Wehner, et al. Age-Associated Changes in Hearts of Male Fischer 344/Brown Norway F1 Rats Ann. Clin. Lab. Sci., January 1, 2006; 36(4): 427 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Eklund, K. S. Hageman, D. C. Poole, and T. I. Musch Impact of aging on muscle blood flow in chronic heart failure J Appl Physiol, August 1, 2005; 99(2): 505 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Volkova, R. Garg, S. Dick, and K. R. Boheler Aging-associated changes in cardiac gene expression Cardiovasc Res, May 1, 2005; 66(2): 194 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. G. Mabley, L. Liaudet, O. V. Evgenov, A. Marton, G. Hasko, M. Kollai, and C. Szabo Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2132 - H2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chouabe, E. Ricci, J. Amsellem, S. Blaineau, Y. Dalmaz, R. Favier, J.-M. Pequignot, and R. Bonvallet Effects of aging on the cardiac remodeling induced by chronic high-altitude hypoxia in rat Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1246 - H1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KJAeR Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading Physiol Rev, April 1, 2004; 84(2): 649 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. McMullen, T. Shioi, W.-Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110{alpha}) Pathway J. Biol. Chem., February 6, 2004; 279(6): 4782 - 4793. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Boluyt, K. Converso, H. S. Hwang, A. Mikkor, and M. W. Russell Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart J Appl Physiol, February 1, 2004; 96(2): 822 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. WELLE, A. BROOKS, and C. A. THORNTON Senescence-related changes in gene expression in muscle: similarities and differences between mice and men Physiol Genomics, March 8, 2001; 5(2): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |